These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 12878651)
21. Modelling mini mental state examination changes in Alzheimer's disease. Mendiondo MS; Ashford JW; Kryscio RJ; Schmitt FA Stat Med; 2000 Jun 15-30; 19(11-12):1607-16. PubMed ID: 10844722 [TBL] [Abstract][Full Text] [Related]
22. MMSE items predict cognitive decline in persons with genetic risk for Alzheimer's disease. Ercoli LM; Siddarth P; Dunkin JJ; Bramen J; Small GW J Geriatr Psychiatry Neurol; 2003 Jun; 16(2):67-73. PubMed ID: 12801154 [TBL] [Abstract][Full Text] [Related]
23. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729 [TBL] [Abstract][Full Text] [Related]
24. Trajectories of decline in cognition and daily functioning in preclinical dementia. Verlinden VJA; van der Geest JN; de Bruijn RFAG; Hofman A; Koudstaal PJ; Ikram MA Alzheimers Dement; 2016 Feb; 12(2):144-153. PubMed ID: 26362597 [TBL] [Abstract][Full Text] [Related]
25. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165 [TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
27. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544 [TBL] [Abstract][Full Text] [Related]
28. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia. Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932 [TBL] [Abstract][Full Text] [Related]
29. The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up. Barocco F; Spallazzi M; Concari L; Gardini S; Pelosi A; Caffarra P J Alzheimers Dis; 2017; 57(3):775-786. PubMed ID: 28304306 [TBL] [Abstract][Full Text] [Related]
30. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study. Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573 [TBL] [Abstract][Full Text] [Related]
31. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years. Wattmo C; Wallin ÅK Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660 [TBL] [Abstract][Full Text] [Related]
32. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Royall DR; Chiodo LK; Polk MS; Jaramillo CJ Neuroepidemiology; 2002; 21(2):68-73. PubMed ID: 11901275 [TBL] [Abstract][Full Text] [Related]
33. Preclinical AD predicts decline in memory and executive functions in subjective complaints. van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134 [TBL] [Abstract][Full Text] [Related]
34. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Wattmo C; Minthon L; Wallin ÅK Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213 [TBL] [Abstract][Full Text] [Related]
35. Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia. Solomon A; Dobranici L; Kåreholt I; Tudose C; Lăzărescu M Int J Geriatr Psychiatry; 2011 Dec; 26(12):1244-51. PubMed ID: 21500282 [TBL] [Abstract][Full Text] [Related]
36. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113 [TBL] [Abstract][Full Text] [Related]
37. [Clinical presentation of Moroccan cases with Alzheimer's disease]. El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896 [TBL] [Abstract][Full Text] [Related]
38. Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem. Tondo G; De Marchi F; Terazzi E; Prandi P; Sacchetti M; Comi C; Cantello R Neurol Sci; 2018 Sep; 39(9):1585-1589. PubMed ID: 29931515 [TBL] [Abstract][Full Text] [Related]
39. Predictors of future cognitive decline in persons with mild cognitive impairment. Xie H; Mayo N; Koski L Dement Geriatr Cogn Disord; 2011; 32(5):308-17. PubMed ID: 22286544 [TBL] [Abstract][Full Text] [Related]
40. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]